期刊文献+

中医医院耐药葡萄球菌属检测分析 被引量:4

Detection of staphylococcus in hospital of traditional Chinese medicine
原文传递
导出
摘要 目的了解医院2008年10月-2010年4月门诊和住院患者耐药葡萄球菌属感染现状,为临床抗感染治疗提供依据。方法同步检测葡萄球菌属产β-内酰胺酶菌株、耐甲氧西林葡萄球菌菌株、红霉素诱导克林霉素耐药菌株等3种类型耐药菌的耐药表型。结果 141株葡萄球菌属中产β-内酰胺酶菌株阳性率95.7%;耐甲氧西林葡萄球菌(MRS)阳性率63.8%;红霉素诱导克林霉素耐药菌株阳性率(D试验阳性)39.0%;红霉素耐药率高达91.5%;克林霉素非诱导耐药率为41.1%,克林霉素总耐药率为80.0%;红霉素诱导克林霉素耐药菌株在MRS中为36.9%,甲氧西林敏感葡萄球菌(MSS)中为43.3%。结论注重葡萄球菌属多种耐药性检测,根据药敏结果合理应用抗菌药物。 OBJECTIVE To understand the infection condition and drug resistance superficies of Staphylococcus in our hospital from Oct 2008 to Apr 2010 and offer suggestions for treatment of clinical infection.METHODS K-B method was used for β-lactam enzyme,MRS and CM inductivity drug resistance(D test) synchronization test of Staphylococcus.RESULTS In 141 individual Staphylococcus,β-lactam enzyme(+) was 95.7%;MRS was 63.8%;D test(+) was 39.0%,E drug resistance was 91.5%;CM non-inductivity drug resistance was 41.1%;CM totally drug resistance was 80.0%;D test(+) Staphylococcus in MRS was 36.9%,in MSS was 43.3%.CONCLUSION It should pay attention to the multiple drug resistance of Staphylococcus and rationally select antibiotics based on drug susceptibility.
作者 范虹 李彦锋
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2011年第15期3267-3268,共2页 Chinese Journal of Nosocomiology
关键词 葡萄球菌属 Β-内酰胺酶 耐甲氧西林 克林霉素 D试验 Staphylococcus β-lactam enzyme Methicillin-resistance Clindamycin D-test
  • 相关文献

参考文献3

二级参考文献12

  • 1赵建平,周秀岚,贾少荣,孙丽萍,张秀屏,冯笑梅.耐甲氧西林葡萄球菌的耐药性监测及分析[J].中华医院感染学杂志,2004,14(9):1052-1054. 被引量:26
  • 2李家泰,齐慧敏,李耘,代表中国细菌耐药监测研究组.2002—2003年中国医院和社区获得性感染革兰阳性细菌耐药监测研究[J].中华检验医学杂志,2005,28(3):254-265. 被引量:224
  • 3沈定霞,罗燕萍,徐雅萍,张秀菊,周光.葡萄球菌对红霉素和克林霉素的诱导耐药性研究[J].中华检验医学杂志,2005,28(4):400-402. 被引量:114
  • 4周薇薇,罗燕萍,张秀菊.516株金黄色葡萄球菌对9种抗生素的耐药性分析[J].中华医院感染学杂志,2005,15(9):1054-1055. 被引量:23
  • 5Oldfield EC. No mercy iron: MRSA [J]. Rew Gostroenterol Disord, 2004,4(2) : 95-96.
  • 6Ito T,Katayama Y,Asada K,et al. Structural comparision of three types of Staphylococcus cassette chromosome mec integrated in the chromosome in methicillin resistance in Staphyloccus aureus [J]. Antimicrob Agent Chemother,2001,45(5) :1323-1336.
  • 7Levin TP, Suh B, Axelrod P, et al. Potential clindamycin resistance in clindamycin-susceptible,erythromycin-resistant Staphylococcus aureus:Report of a clinical failure [J]. Antimieroh Agents Chemother,2005,49 (3) ;1222-1224.
  • 8National Commettee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing[S]. Fifteenth informational supplement[J]. NCCLS document M100-S15. Wayne,Pennsylvania:2005.1-159.
  • 9Steward CD, Raney PM, Morrell AK,et al. Testing for induction of clindamycin resistance in erythromycin-resistant isolates of Staphylococcus aureus[J]. J Clin Microbiol,2005,43(4) :1716-1721.
  • 10Spiliopoulou I, Papandreou PE, Dimitracopoulos G. ermC Is the predominant genetic determinant for the expression of resistance to macrolides among methicillin-resistant Staphylococcus aureus clinical isolates in Greece[J]. J Antimicrob Chemother, 2004,53 : 814-817.

共引文献59

同被引文献32

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部